Quadax
Customer Login
Need Help?
Careers & Culture
Events
Quadax Blog
About
Why Choose Quadax?
The Quadax Story
Quadax Leadership
Recognition & Affiliations
Partner With Quadax
Compliance
Who We Help
Durable Medical Equipment (DME)
Unified RCM Solution
Patient Access
Claims Management
Reimbursement Management
Denial Management
Patient & Client Engagement
Analytics & Reporting
Hospitals & Health Systems
Unified RCM Solution
Analytics & Reporting
Claims Management
Denial Management
Front End RCM
Healthcare Patient Access Solutions
Healthcare Patient Engagement Solutions
Reimbursement Management
Epic Resolute Integration
Labs & Diagnostic Providers
Complete RCM Solution
Patient Access
Claims Management
Reimbursement Management
Denial Management
Patient & Client Engagement
Analytics & Reporting
Integration Capabilities
PAMA Reporting
Medical Billing & Follow-Up Companies
Unified RCM Solution
Claims Management
Reimbursement Management
Denial Management
Analytics & Reporting
Physician Groups & Specialty Practices
Unified RCM Solution
Analytics & Reporting
Claims Management
Denial Management
Front End RCM
Healthcare Patient Access Solutions
Healthcare Patient Engagement Solutions
Reimbursement Management
Post-Acute & Long-Term Care
Unified RCM Solution
Claims Management
Reimbursement Management
Denial Management
Analytics & Reporting
Resources
Case Studies and Client Testimonials
Hospitals & Physician Groups Best Practices
Lab & Diagnostic Provider Best Practices
Quadax News
Contact Sales
Schedule A Demo
UHC Deadline for Lab Test Registry Delayed Indefinitely
Implementation delayed until further notice.
Continue Reading...
Four Challenges Facing Healthcare Providers in the COVID-19 Pandemic
There has arguably never been a time like this before in healthcare—when receiving maximum reimbursement for every patient is critical.
Continue Reading...
CMS Price Transparency Rule – What You Need to Know
When patients don’t understand what they are being charged and what they will owe, it leads to financial stress on the patient and the possibility of not being able to pay their medical bills.
Continue Reading...
Navigating Reimbursement for Liquid Biopsy Cancer Testing
Thirty-eight percent of private payers now cover some type of ctDNA-based panel testing. Is your lab aware of evolving payment policies?
Continue Reading...
COVID-19: Insurers Exempt from Covering Workplace Testing
Must Cover “Medically Appropriate” Tests Only
Continue Reading...
Previous
Next
Subscribe to Updates
Categories
Business Analytics
(16)
Claims Management
(74)
Compliance and Security
(20)
COVID-19 Resources
(29)
Denials, Appeals and Audit Management
(25)
Industry News and Trends
(99)
Integration, Implementation & Support
(12)
Operational Success
(52)
Patient Access Management
(23)
Patient Engagement
(25)
Quadax Industry News Bulletin
(3)
Quadax News & Culture
(12)
Reimbursement Management
(48)
Telemedicine
(8)
Share with your network
